2011
DOI: 10.1016/j.phrs.2011.02.009
|View full text |Cite
|
Sign up to set email alerts
|

Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…The study indicated that long-lasting antinociception was completely blocked by the 5-HT 2A receptor antagonists, Ketanserin [ 27 ]. Peiró et al reported 5-HT inhibition of the kappa-opioid component of morphine antinociceptive effects and the possibility that this serotonergic inhibition could be reversed through 5-HT2 receptor antagonist Ketanserin [ 28 ]. Crisp et al reported that intrathecal administration of 5-HT agonist, 8-OH-DPAT produced hyperalgesia with the tail-flick test and analgesia with the hot-plate test, and 5-HT 1B agonist, TFMPP, 5-HT 2A agonist and DOI phenylbiguanide produced analgesia with the hot-plate test in the rat [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…The study indicated that long-lasting antinociception was completely blocked by the 5-HT 2A receptor antagonists, Ketanserin [ 27 ]. Peiró et al reported 5-HT inhibition of the kappa-opioid component of morphine antinociceptive effects and the possibility that this serotonergic inhibition could be reversed through 5-HT2 receptor antagonist Ketanserin [ 28 ]. Crisp et al reported that intrathecal administration of 5-HT agonist, 8-OH-DPAT produced hyperalgesia with the tail-flick test and analgesia with the hot-plate test, and 5-HT 1B agonist, TFMPP, 5-HT 2A agonist and DOI phenylbiguanide produced analgesia with the hot-plate test in the rat [ 29 ].…”
Section: Discussionmentioning
confidence: 99%